02-02-2022 / Learn how investigators at George Washington University Cancer Center leveraged synthetic peptides to activate and amplify patient-derived T cells to generate specific T cell immunotherapies for medulloblastoma.

11-17-2021 / uncovering-immunogenic-peptides-of-clinical-significance-in-crispr-cas9

11-03-2021 / SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

06-16-2021 / Learn about how vaccine or infection-induced T cell responses against the original SARS-CoV-2 strain remain protective against new variants.

04-12-2021 / Learn about a new approach to the treatment of Parkinson's disease alpha-synuclein pathology that uses a cell-penetrating peptide to induce proteasome degradation of alpha-synuclein.

01-18-2021 / Non-Coding Sequences Expand Neoantigens for Therapy

01-11-2021 / How the Proteasome Modulates the Immunopeptidome

01-03-2021 / α-Hemolysin derived from Staphylococcus aureus Promotes Inflammation Resolution through Generation of Specialized Pro-resolving Mediators

10-11-2020 / Peptide libraries allow investigators to identify epitopes inducing T cell activation which may be used in the design of vaccines to treat infectious diseases such as COVID.